Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia

相似書籍

• An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(−/−) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia
  由: Schmidt, Paul J., et al.
  出版: (2013)
• Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia
  由: Casu, Carla, et al.
  出版: (2016)
• Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
  由: Karami, Hossein, et al.
  出版: (2017)
• Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions
  由: Neufeld, Ellis J.
  出版: (2006)
• Treating thalassemia major-related iron overload: the role of deferiprone
  由: Berdoukas V, et al.
  出版: (2012-10-01)